BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic MelanomaDennie T. Frederick, Jennifer A. Wargo, Cecilia Lezcano et al.|Clinical Cancer Research|2013Cited by 938
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapyMeenu Sharma, Willem W. Overwijk|Nature Communications|2020Cited by 169